PK tracks the life cycle of a compound within the system. It is commonly summarized by the acronym ADME : Absorption: How the drug enters the bloodstream. Distribution: How it travels to various tissues and organs.
Using mathematical models to integrate PD, PK, and disease progression. is now accepted by the FDA. MIDD allows developers to simulate a Phase III trial using virtual patients, predicting optimal dosing for elderly, pediatric, or renally-impaired populations without exposing them to risk.
Hundreds to thousands of patients across multiple global sites. pharmacology in drug discovery and development
The landscape of drug discovery is evolving rapidly due to technological breakthroughs. Pharmacology is integrating these new tools to make the pipeline faster and more precise.
The drug discovery and development pipeline relies heavily on two primary branches of pharmacology: , which analyzes what a drug does to the body, and pharmacokinetics (PK) , which maps what the body does to the drug. Together, these disciplines form a framework that dictates the success of small molecules, biologics, and novel advanced therapeutics. PK tracks the life cycle of a compound within the system
: The concentration of the drug required to produce a specific percentage of its maximum response ( EC50cap E cap C sub 50 IC50cap I cap C sub 50 Efficacy : The maximum therapeutic effect ( Emaxcap E sub m a x end-sub ) the compound can achieve, regardless of dose.
The Architect of Modern Medicine: Pharmacology in Drug Discovery and Development Using mathematical models to integrate PD, PK, and
The initial phase of making a medicine relies heavily on experimental pharmacology to establish biological relevance.
A drug with outstanding PD (it shuts down a cancer enzyme perfectly) but terrible PK (it is destroyed by stomach acid or cleared by the liver in 2 minutes) will never become a medicine. Pharmacology is the science of measuring, predicting, and optimizing this window.